Madhusudan Soumya, Vimala Smita, S Manikandan, Goyal Ayesha, Singi Yatiraj
Anaesthesiology, St. John's Medical College, Bengaluru, IND.
Neuroanaesthesia, Sree Chitra Tirunal Institute for Medical sciences and Technology, Thiruvananthapuram, IND.
Cureus. 2024 Jul 13;16(7):e64448. doi: 10.7759/cureus.64448. eCollection 2024 Jul.
Mannitol is widely used in neurosurgical units to mitigate raised intracranial pressure and cerebral edema, crucial in postoperative management. Its hyperosmolar properties reduce brain extracellular fluid, thereby altering cerebral perfusion and cardiac dynamics. However, the temporal and combined effects of mannitol on cardiovascular and cerebrovascular parameters remain inadequately explored in postoperative settings.
This prospective observational study enrolled 20 adult patients who underwent elective craniotomies for tumor excision. Mannitol was administered to the patients at a dose of 0.5 mg/kg/dose as a bolus dose over 20 to 30 minutes. The time interval was eight hours between the doses (scheduled dosing). Patients received their first dose of mannitol in the ICU after eight hours of intraoperative dose. The patients were given mannitol for two postoperative days and followed up for two days in the postoperative period. Transthoracic echocardiography and transcranial color Doppler were used to assess cardiovascular and cerebrovascular parameters at multiple intervals post-mannitol administration.
Significant increases in mean flow velocities were observed bilaterally immediately post-mannitol administration on the first postoperative day, indicative of improved cerebral blood flow. However, these changes were transient, with no significant variations noted on the second postoperative day. Cerebrovascular resistance, as measured by the pulsatility index, showed non-significant changes bilaterally across both days. Cardiovascular parameters, including stroke volume and cardiac output, remained stable throughout the study period.
Mannitol administration at 0.5 g/kg in postoperative neurosurgical patients transiently improves cerebral perfusion without causing significant hemodynamic instability. This study underscores the importance of monitoring both cerebrovascular and cardiovascular parameters post-mannitol administration to optimize patient management and outcomes.
甘露醇在神经外科广泛用于减轻颅内压升高和脑水肿,这在术后管理中至关重要。其高渗特性可减少脑细胞外液,从而改变脑灌注和心脏动力学。然而,在术后环境中,甘露醇对心血管和脑血管参数的时间及联合影响仍未得到充分研究。
这项前瞻性观察性研究纳入了20例接受择期开颅肿瘤切除术的成年患者。以0.5 mg/kg/剂量的剂量将甘露醇作为推注剂量在20至30分钟内给予患者。剂量之间的时间间隔为8小时(预定给药)。患者在术中给药8小时后在重症监护病房接受第一剂甘露醇。患者术后两天给予甘露醇,并在术后随访两天。在给予甘露醇后的多个时间间隔使用经胸超声心动图和经颅彩色多普勒评估心血管和脑血管参数。
术后第一天给予甘露醇后立即观察到双侧平均流速显著增加,表明脑血流量改善。然而,这些变化是短暂的,术后第二天未观察到显著变化。通过搏动指数测量的脑血管阻力在两天内双侧均无显著变化。包括每搏输出量和心输出量在内的心血管参数在整个研究期间保持稳定。
术后神经外科患者给予0.5 g/kg甘露醇可短暂改善脑灌注,而不会引起显著的血流动力学不稳定。本研究强调了在给予甘露醇后监测脑血管和心血管参数对于优化患者管理和结局的重要性。